Monday 11/30 Insider Buying Report: LMNX, VIVO

Monday 11/30 Insider Buying Report: LMNX, VIVO

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

On Wednesday, Luminex's Director, Stephen L.

Eck, made a $100,501 buy of LMNX, purchasing 4,487 shares at a cost of $22.40 each.

Eck was up about 6.3% on the buy at the high point of today's trading session, with LMNX trading as high as $23.81 at last check today.

Luminex is trading up about 3.3% on the day Monday.

This buy marks the first one filed by Eck in the past year.

And also on Wednesday, Director Anthony P.

Bihl III purchased $88,266 worth of Meridian Bioscience, purchasing 5,000 shares at a cost of $17.65 a piece.

Before this latest buy, Bihl III made one other buy in the past year, purchasing $89,950 shares at a cost of $17.99 each.

Meridian Bioscience is trading up about 1% on the day Monday.

Bihl III was up about 8.0% on the buy at the high point of today's trading session, with VIVO trading as high as $19.06 in trading on Monday.